RZRiccardo Zanzi

Riccardo Zanzi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Riccardo Zanzi has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trends in Pancreatic Cancer Mortality in Europe and the USA, 1990-2024, and Predictions to 2030

    by Riccardo Zanzi, Gianfranco Alicandro, Carlo La Vecchia, Silvia Mignozzi, Claudia Santucci

    Introduction Pancreatic cancer is the fourth leading cause of cancer-related mortality in Europe, accounting for approximately 140,000 deaths in 2024. While mortality for many major cancers has declined over recent decades, pancreatic cancer did not decline and is characterized by a poor prognosis and high fatality rates. This reflects the lack of population screening, the high proportion of diagnoses at advanced stages due to nonspecific symptoms, and the limited efficacy of current treatment. Monitoring mortality trends and geographical inequalities across Europe is therefore essential to assess the evolving disease burden. Objectives The aim of this study was to describe pancreatic cancer mortality trends in Europe and the USA from 1990 to 2024 and to investigate differences across countries and sexes. Methods Pancreatic cancer death counts for the period 1990-2024 were obtained from the World Health Organization, while population estimates were retrieved from the United Nations Population Division. Analyses were restricted to European countries with at least 1 million inhabitants, no ongoing armed conflicts, medium-to-high mortality data quality (usability ≥60%), and at least 20 years of available data. The USA was also considered. Age-standardised mortality rates (ASMRs) per 100,000 were computed for each country and the EU-27 using the world standard population. Joinpoint regression models were used to identify significant changes in mortality trends, estimating annual percentage changes (APCs) for each time segment and average annual percentage changes over the entire study period. For the EU-27 and the USA, mortality rates were projected up to 2030. Results Twenty-nine European countries and the USA were included. In the triennium 2020-2022, ASMRs for pancreatic cancer in the EU-27 were 8.06 per 100,000 males and 5.15 per 100,000 females, while in the USA they were 7.35 in males and 5.59 in females. The highest mortality rates were observed in Hungary, Latvia, and the Czech Republic, where ASMRs exceeded 10 per 100,000 males and 7 per 100,000 females. Recent trends showed decreasing mortality among males in the EU-27 (APC 2018-2023: -0.6, 95% CI: -1.0, -0.2) and no significant changes among females (APC 2019-2023: -0.3, 95% CI: -1.0, 0.4). In the USA, mortality rates did not significantly change among males (APC 2001-2023: -0.0, 95% CI: -0.1, 0.1), whereas an upward trend was observed among women (APC 2002-2023: +0.2, 95% CI: 0.1, 0.3). By 2030, ASMRs in the EU-27 is predicted to reach 7.64 (95% Prediction interval, PI: 7.38, 7.91) per 100,000 males and 5.56 (95% PI: 5.23, 5.91) per 100,000 females in the EU-27. Corresponding figure for the USA were 7.36 (95% PI: 7.26, 7.46) per 100,000 males and 5.69 (95% PI: 5.59, 5.78) females. Conclusions Overall, pancreatic cancer mortality in the EU-27 and the USA has stopped rising among men since the mid-2020s and is predicted to moderately decline through 2030. However, several European countries showed stable or increasing mortality, while trends remained less favourable among women. The results confirm the limited progress in reducing the burden of this highly lethal malignancy and reveal important geographical inequalities across Europe, reflecting differences in tobacco smoking, obesity, and diabetes.

  • The interaction between glucose levels and body mass index on the regulation of the circulating sphingolipidome in humans

    by Camillo Morano, Lucia Centofanti, Michele Dei Cas, Riccardo Zanzi, Giuseppe De Pinto, Monica Bignotto, Paola Zermiani, Elena Bianco, Federica Samartin, Sara Penati, et al.

    Sphingolipid glycosylation is an enzymatic process that does not follow the pattern of nonenzymatic hemoglobin glycosylation. Unexpectedly, hexosyl- and lactosylceramides decreased in impaired fasting glucose and diabetes, with and without obesity. On the other hand, dihydroceramides increased in overweight/obesity with prediabetes/diabetes. The circulating sphingolipidome is differentially regulated in humans according to sex, glucose, and BMI.


  • Open Access

    The Reasons to Get Vaccinated: A Cross-Sectional Study on HPV Vaccination Adherence in a Northern Italian University

    by Pier Mario Perrone, Riccardo Zanzi, Elia Biganzoli, Fabrizio Pregliasco, Silvana Castaldi

    Background/Objectives: Human papillomavirus (HPV) represents a major public health challenge due to its high prevalence and the complications arising from infection. The aim of the study was to investigate the reasons for adherence to the HPV vaccination campaign offered by the University of Milan to its students. Methods: A questionnaire, distributed via QR code, was utilized to investigate the motivations behind participation in the vaccination campaign, as well as the characteristics of the population participating in the vaccination campaign carried out at the University of Milan. Concurrently, a comprehensive analysis of the characteristics of students was also carried out at the vaccination sites where it was conducted, categorizing them into university hospitals and university campuses. Results: A comparison of vaccination sites revealed a significant disparity between hospitals and universities with regard to gender, age, and faculty. A higher average age (25 versus 24 years) and a higher prevalence of females (53.9% versus 51.1%) were observed in hospitals. The findings of the regression model demonstrate that demographic factors exert an influence on only two reasons for participation, with male gender proving a predictive factor for the response option entitled “It is a responsibility towards one’s partner(s)”. Furthermore, enrolment in a course of study has been found to correlate positively with the response option entitled “I have been convinced by advertising campaigns/friends/acquaintances”. Conclusions: A vaccination campaign implemented within educational institutions is a fundamental strategy for enhancing vaccination uptake rates among young population. Conversely, the utilization of health promotion interventions, such as pre-vaccination promotional campaigns, does not seem to be a pivotal factor in enhancing uptake.